After rounding, constipation and diarrhea rates were 11% and 10% for GLP-1 users and non-users, respectively
A monitoring visit is scheduled at 4 weeks
Zhang, X., Rojas, J
Question2: Are there any side effects
Lilly reported that patients on retatrutide lost a large average percentage of body weight, and some patients moved below the obesity range
Key Areas of Research: Structural: Collagen, matrix, tendon Vascular: Angiogenesis, nitric oxide, repair Dermatological: Wound closure, vessel growth, cells Systemic: Protection, viability, recovery Together, these findings suggest broad experimental utility for BPC-157 across multiple biological pathways